Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00023398
DRKS00023398
Recruiting
Not Applicable

Predicting the impact of the gut microbiome on immunosuppressive drug metabolism in kidney transplant patients - PRISMA

niversitätsklinikum Heidelberg0 sites130 target enrollmentOctober 26, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsKidney Transplantation

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Kidney Transplantation
Sponsor
niversitätsklinikum Heidelberg
Enrollment
130
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 26, 2020
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Heidelberg

Eligibility Criteria

Inclusion Criteria

  • •(i) Recipients of a living kidney donor transplant of any age or
  • •patients on the waiting list for deceased kidney donor transplantation of any age
  • •(ii) Treatment with tacrolimus as part of their immunosuppressive regimen during at least two time periods within the study period
  • •(iii) Written informed consent from adult patients, who are able to give consent
  • •(iv) Patient consent and written informed consent from caregivers from underage patient

Exclusion Criteria

  • •(i) Patients with preexisting liver disease defined as cirrhosis, systemic inflammation (infectious, chemical or autoimmune) or hepatic tumors
  • •(ii) Non\- Caucasian patients

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 1
Assessment of the influence of the gut microbiome on tacrolimus pharmacokinetics in healthy volunteersPharmacokinetic trial in healthy volunteers
DRKS00032072niversitätsklinikum Heidelberg, Im Wege der Auftragsverwaltung für die Universität Heidelberg, Medizinische Fakultät Heidelberg20
Recruiting
Phase 3
Targeting the gut microbiome as a treatment for Primary Sclerosing Cholangitis: The Queensland Clinical Network Study
ACTRN12621000792820Princess Alexandra Hospital34
Suspended
Not Applicable
Influence of the intestinal microbiome on the risk of spontaneous bacterial peritonitis in patients with decompensated liver cirrhosisK65K74.6PeritonitisOther and unspecified cirrhosis of liver
DRKS00026834Klinik und Poliklinik für Innere Medizin II Klinikum rechts der Isar der TU München120
Completed
Not Applicable
The analysis of influences on the gut microbiota, the glycometabolism and the peritoneal permeability by the induction of dialysis and the peritonitis prevalence in peritoneal dialysis patients.end stage renal failure
JPRN-UMIN000014814Keio university school of medicine20
Completed
Not Applicable
The intestinal microbiome as a predictive biomarker for efficacy and side effects of CAR-T cell therapy in blood cancersC91.0C83.3Acute lymphoblastic leukaemia [ALL]Diffuse large B-cell lymphoma
DRKS00020506Deutsches Krebsforschungszentrum (DKFZ)66